These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2655606)
1. Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study. Furst DE; Clements PJ; Hillis S; Lachenbruch PA; Miller BL; Sterz MG; Paulus HE Arthritis Rheum; 1989 May; 32(5):584-93. PubMed ID: 2655606 [TBL] [Abstract][Full Text] [Related]
2. The course of skin involvement in systemic sclerosis over three years in a trial of chlorambucil versus placebo. Clements P; Lachenbruch P; Furst D; Paulus H Arthritis Rheum; 1993 Nov; 36(11):1575-9. PubMed ID: 8240434 [TBL] [Abstract][Full Text] [Related]
3. A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma. Pope JE; Bellamy N; Seibold JR; Baron M; Ellman M; Carette S; Smith CD; Chalmers IM; Hong P; O'Hanlon D; Kaminska E; Markland J; Sibley J; Catoggio L; Furst DE Arthritis Rheum; 2001 Jun; 44(6):1351-8. PubMed ID: 11407694 [TBL] [Abstract][Full Text] [Related]
5. [Immediate results of long-term treatment of systemic scleroderma with leukeran]. Olszewska Z Reumatologia; 1978; 16(2):259-66. PubMed ID: 358343 [No Abstract] [Full Text] [Related]
6. A double-blind randomized controlled trial of ketotifen versus placebo in early diffuse scleroderma. Gruber BL; Kaufman LD Arthritis Rheum; 1991 Mar; 34(3):362-6. PubMed ID: 2003858 [TBL] [Abstract][Full Text] [Related]
7. Cyclophosphamide versus placebo in scleroderma lung disease. Tashkin DP; Elashoff R; Clements PJ; Goldin J; Roth MD; Furst DE; Arriola E; Silver R; Strange C; Bolster M; Seibold JR; Riley DJ; Hsu VM; Varga J; Schraufnagel DE; Theodore A; Simms R; Wise R; Wigley F; White B; Steen V; Read C; Mayes M; Parsley E; Mubarak K; Connolly MK; Golden J; Olman M; Fessler B; Rothfield N; Metersky M; N Engl J Med; 2006 Jun; 354(25):2655-66. PubMed ID: 16790698 [TBL] [Abstract][Full Text] [Related]
8. Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy. Berk PD; Goldberg JD; Silverstein MN; Weinfeld A; Donovan PB; Ellis JT; Landaw SA; Laszlo J; Najean Y; Pisciotta AV; Wasserman LR N Engl J Med; 1981 Feb; 304(8):441-7. PubMed ID: 7005681 [TBL] [Abstract][Full Text] [Related]
9. Interferon-alpha does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized, double-blind, placebo-controlled trial. Black CM; Silman AJ; Herrick AI; Denton CP; Wilson H; Newman J; Pompon L; Shi-Wen X Arthritis Rheum; 1999 Feb; 42(2):299-305. PubMed ID: 10025924 [TBL] [Abstract][Full Text] [Related]
10. Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial. Seibold JR; Korn JH; Simms R; Clements PJ; Moreland LW; Mayes MD; Furst DE; Rothfield N; Steen V; Weisman M; Collier D; Wigley FM; Merkel PA; Csuka ME; Hsu V; Rocco S; Erikson M; Hannigan J; Harkonen WS; Sanders ME Ann Intern Med; 2000 Jun; 132(11):871-9. PubMed ID: 10836913 [TBL] [Abstract][Full Text] [Related]
17. Ketanserin in the treatment of systemic sclerosis: a double-blind controlled trial. Ortonne JP; Torzuoli C; Dujardin P; Fraitag B Br J Dermatol; 1989 Feb; 120(2):261-6. PubMed ID: 2647122 [TBL] [Abstract][Full Text] [Related]
18. [Hair changes in immunosuppressive therapy]. Kostanecki W; Mazurkiewicz W; Górkiewicz A; Zborzil J Z Haut Geschlechtskr; 1971 Oct; 46(19):704-8. PubMed ID: 5137252 [No Abstract] [Full Text] [Related]
19. Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study. Wigley FM; Korn JH; Csuka ME; Medsger TA; Rothfield NF; Ellman M; Martin R; Collier DH; Weinstein A; Furst DE; Jimenez SA; Mayes MD; Merkel PA; Gruber B; Kaufman L; Varga J; Bell P; Kern J; Marrott P; White B; Simms RW; Phillips AC; Seibold JR Arthritis Rheum; 1998 Apr; 41(4):670-7. PubMed ID: 9550476 [TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis. Ren S; Wang Y; Xian L; Toyama T; Jardine M; Li G; Perkovic V; Hong D PLoS One; 2017; 12(9):e0184398. PubMed ID: 28898290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]